Long-term survival achieved by repeated administration of ramucirumab after drug holidays due to proteinuria in recurrent gastric cancer.

Naoyuki UehataKeita KouzuHironori TsujimotoHidekazu SugasawaKotaro WakamatsuYoji KishiHideki Ueno

Published in: Surgical case reports (2021)

In conclusion, even if RAM withdrawal led to disease progression, re-administration of RAM monotherapy while considering its side effects reduced the tumor size and provided long-term survival benefits.

Keyphrases

combination therapy
open label
emergency department
randomized controlled trial
clinical trial
adverse drug
electronic health record